NCT00220324View on ClinicalTrials.gov

Pearl Index Study With Low Dose Combined Oral Contraceptive

PHASE3CompletedINTERVENTIONAL
Enrollment

840

Participants

Timeline

Start Date

February 29, 2004

Study Completion Date

November 30, 2005

Conditions
Contraception
Interventions
DRUG

Minisiston (SH D00342A)

Daily oral administration in 21 days per cycle, followed by a 7-day pill-free interval

Trial Locations (25)

10179

Berlin

10247

Berlin

10409

Berlin

12435

Berlin

13507

Berlin

30159

Hanover

38820

Halberstadt

38821

Halberstadt

39112

Magdeburg

39120

Magdeburg

39126

Magdeburg

39288

Burg

39435

Egeln

98527

Suhl

01067

Dresden

01099

Dresden

01108

Dresden

01324

Dresden

04463

Großpösna

04207

Leipzig

04277

Leipzig

04279

Leipzig

06449

Aschersleben

06917

Jessen

07579

Weida

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY